Pharmaceutical CDMO with APIs, intermediates, and finished products across 10 global locations
Midas Pharma operates as a contract development and manufacturing organization (CDMO) across the full pharmaceutical value chain—from active ingredients through finished products. The tech stack reveals a traditional pharma operations profile (Excel, SQL, Salesforce, IQVIA) undergoing deliberate modernization: Azure and Snowflake adoption signals migration toward cloud-native data infrastructure, while ThoughtSpot and Power BI investments indicate a push for self-service analytics. The project list (AI pilots, data mart training, system validation) and hiring deceleration suggest the company is in a selective scaling phase focused on capability-building rather than headcount expansion.
Midas Pharma is a family-owned pharmaceutical manufacturer based in Ingelheim, Germany, founded in 1988. The company operates across 10 locations in major pharmaceutical markets, serving as a full-service partner for pharma and biotech customers. Service lines span active pharmaceutical ingredients (APIs), intermediates, custom synthesis, finished product manufacturing and development, and quality management. With over 250 employees, the company combines three decades of sector experience with established networks across multiple pharmaceutical verticals, positioning itself as a project coordinator for complex pharmaceutical workflows.
Core tools: Excel, SQL, Python, Salesforce Sales Cloud, IQVIA, ThoughtSpot, Power BI, Tableau, AWS, Microsoft Office. Currently adopting: Azure, Copilot Studio, Snowflake for analytics and cloud infrastructure modernization.
Ingelheim, Rhineland-Palatinate, Germany. The company operates 10 locations across major pharmaceutical markets worldwide.
Other companies in the same industry, closest in size